Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-24 @ 11:41 PM
NCT ID:
NCT05305651
Eligibility Criteria:
Inclusion Criteria:
* Participants must be adult and of greater than or equal to (\>=) 18 years of age or older at the time of consent
* Participants must be immunocompromised (IC) population eligible to receive sotrovimab
* A positive polymerase chain reaction (PCR) or antigen test for SARS-CoV-2 through clinical testing or routine screening undertaken as part of clinical management
* Prescribed treatment with sotrovimab as standard of clinical care
* Able to provide informed consent and willing to adhere to study-related procedures
Exclusion Criteria:
* Participants who require hospitalization (related or not to COVID-19) at baseline
* Participants who initiated sotrovimab therapy in inpatient settings
* Participants unable to perform nasal/oropharyngeal sample collection
* Blinded participants from other COVID-19 related trials
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05305651
Study Brief:
Protocol Section:
NCT05305651